IHS Chemical Week

EnviroTech :: Regulatory

Pharmaceutical Contamination in U.S. Spreads to Germany, China is Prime Suspect

10:13 AM MDT | March 11, 2008 |

Alex Scott

Contaminated batches of the blood thinning drug heparin that are potentially lethal have been discovered on the market in Germany. Producers have recalled supplies of heparin in the country in the past week following severe reactions to batches of the drug by up to 100 patients. The contamination cases in Germany follow the withdrawal at the end of February of contaminated batches of heparin in the U.S. that have been linked to as many as 800 adverse patient reactions and 19 patient deaths. The contaminated heparin used in the U.S. has been traced back to...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa